Otolith Labs

Solving Vertigo

Otolith Labs is pioneering the first medical wearable for the treatment of chronic vertigo, a symptom experienced by 4-5 million Americans. Otolith’s patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo. This novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers. 

 

OtoBand Rendering

Our Team

Sam Owen

Sam Owen

Founder & CEO

Didier Depireux, Ph.D.

Didier Depireux, Ph.D.

Chief Science Officer

Jon Akers

Jon Akers

Chief Product Officer

Tom Hardart

Tom Hardart

Chief Business Officer

Jack Daggitt

Jack Daggitt

Chief Operating Officer

Dan Wagner

Dan Wagner

Chief Commercial Officer

Kevin Franck, Ph.D.

Kevin Franck, Ph.D.

Chief Clinical Officer

Daniel Stolzberg, Ph.D.

Daniel Stolzberg, Ph.D.

Senior Research Scientist

Alesia Robinson

Alesia Robinson

Clinical Research Manager

Kevin Grant, MS

Kevin Grant, MS

Clinical Research Coordinator II

Eliza Keller

Clinical Research Coordinator

Lauren Bruinsma

Lauren Bruinsma

Biomedical Engineer

Matt True

Biomedical Engineer

Annalise Kelloff

Annalise Kelloff

Marketing Coordinator

Medical Advisory Board

Medical Advisory Board

Michael E. Hoffer, MD

Michael E. Hoffer, MD

Jeffrey D. Sharon, MD

Jeffrey D. Sharon, MD

Kristen K. Steenerson, MD

Kristen K. Steenerson, MD

Steven J. Eliades, MD, PhD

Steven J. Eliades, MD, PhD

Hinrich Staecker, MD, PhD

Hinrich Staecker, MD, PhD

Shin Beh, MD, FAAN, FAHS

Shin Beh, MD, FAAN, FAHS

Our History

Eight Years In The Making

Otolith Lab’s was founded in 2015 by Sam Owen, while Sam was pursuing a PHD in Physics at Georgetown University. Shortly after founding the company, Otolith Labs was accepted into the Halcyon incubator, a startup incubator focused on scalable and sustainable ventures which have a positive impact. In 2016, Otolith conducted its first clinical study and in 2018, Land Rover Jaguar validated the technology in the treatment of Motion Sickness. In 2020, Otolith won the Ignite the Night competition at CES and prestigious NASA iTech Prize.

Otolith Labs is backed by experienced medical investors, including several Ear, Nose and Throat Doctors. The company is based in Washington, D.C.

“Otolith Labs was founded to help the more than 15 million Americans who have chronic difficulties relating to balance and vertigo with simple, non-invasive technology. We are committed to solving this common health challenge.

Sam Owen

Founder & CEO

Join Us

Otolith Labs believes the strength of our company lies with our team of hardworking talent in the scientific, engineering, and business development spaces. We strive to work with a diverse group of people, with different backgrounds, thinking, and skills, to create an environment where innovation thrives. Our team is committed to helping mitigate the effects of vertigo because we understand the difficulties suffered and the future we can help shape.

Collaborative Community

Collaborative Community

We work together and support one another to foster a culture where creativity and innovation flourish.

Cutting-Edge  Thinking

Cutting-Edge Thinking

Through years of research and development, we are pioneering the first wearable medical device to treat vertigo.

Creating Life-Changing Solutions

Creating Life-Changing Solutions

Our team is passionate and sincere about developing a product that will improve millions of lives.

Connect with us

ISO13485 Certification

About

© 2024 Otolith Labs, Inc.